Kennedy Capital Management’s DocGo DCGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-721,399
Closed -$2.4M 691
2024
Q3
$2.4M Buy
721,399
+8,605
+1% +$29.3K 0.05% 479
2024
Q2
$2.2M Sell
712,794
-764,078
-52% -$2.52M 0.05% 501
2024
Q1
$5.97M Sell
1,476,872
-314,520
-18% -$1.19M 0.12% 280
2023
Q4
$10M Sell
1,791,392
-80,041
-4% -$460K 0.22% 160
2023
Q3
$9.97M Sell
1,871,433
-322,688
-15% -$2.62M 0.24% 137
2023
Q2
$20.6M Buy
2,194,121
+680,409
+45% +$5.97M 0.48% 34
2023
Q1
$13.1M Buy
1,513,712
+1,116,255
+281% +$9.85M 0.39% 65
2022
Q4
$2.81M Sell
397,457
-15,922
-4% -$134K 0.08% 374
2022
Q3
$4.1M Buy
+413,379
New +$3.73M 0.12% 300

Other funds holding DCGO

Kennedy Capital Management's DCGO Position: Q4 2024 in Review

Kennedy Capital Management sold out of DocGo (DCGO) in Q4 2024, closing a stake of 721,399 shares — an estimated $2.4M sold.

Kennedy Capital Management first reported a position in DCGO in Q3 2022 and held it in 9 quarters. The position peaked at $20.6M in Q2 2023. 128 funds tracked by Wall St. Rank hold DCGO as of Q4 2024.

  • Kennedy Capital Management reported no remaining DocGo position as of Q4 2024 after selling out during the quarter.
  • Kennedy Capital Management sold 721,399 DocGo shares in Q4 2024, an estimated $2.4M.
  • Kennedy Capital Management first reported a position in DocGo in Q3 2022 and held it in 9 quarters.
  • Kennedy Capital Management's DocGo position peaked at $20.6M in Q2 2023.
  • 128 funds tracked by Wall St. Rank held DocGo as of Q4 2024.

Based on Kennedy Capital Management's 13F filing for Q4 2024, filed 13 Feb 2025.